Estrogen decline causes vaginal dryness, reduced sensitivity and slower arousal, but these treatable conditions shouldn't be accepted as inevitable aging. Underlying health issues like diabetes, cardiovascular disease, depression and medication side effects significantly impact sexual function in women over 50.
Sex After 50: How Women Can Maintain Pleasure Despite Hormonal Changes
Related Coverage
Endocrinologista explica que perda de peso após os 40 anos exige análise integrada de hormônios, sono e composição corpo…
Folha de S.Paulo · Aug 25 Zema critica vacinação obrigatória e nega golpe em entrevista ao Jornal NacionalCandidato presidencial Romeu Zema declarou-se contrário à vacinação obrigatória e prometeu anistia aos condenados pelos …
Super Rádio Tupi · Aug 25 Nova espécie de cão-urso do Mioceno revela predador pré-histórico desconhecidoPesquisadores identificaram uma nova espécie de cão-urso (anficionídeo) em fósseis de 16 milhões de anos, ampliando o co…
REDE BRASIL DE TELEVISÃO · Aug 25 Diagnóstico precoce de Alzheimer amplia possibilidades de tratamento, alerta FebrazCampanha Setembro Lilás 2026 alerta sobre importância do diagnóstico inicial de Alzheimer, com 84,3% de subdiagnóstico n…
Bias & Framing
No detailed analysis data available for this lens. Try re-running lenses from the admin panel.
Geopolitical Impact
This is a health/medical article about women's sexuality after 50, not a geopolitical matter. No international implications exist.
Economic Lens
Healthcare article on menopausal women's sexual health has limited direct economic impact; primarily affects pharmaceutical and medical device sectors serving hormone replacement and intimate care products.
Increased awareness may drive demand for treatment options and intimate care products among women 50+, potentially increasing healthcare spending in this demographic; reduces stigma around discussing sexual health, potentially expanding addressable market for related products and services.
May influence healthcare coverage decisions regarding hormone replacement therapy and sexual health treatments; could prompt public health campaigns normalizing menopausal sexual health discussions; potential regulatory review of over-the-counter intimate care product claims.